Limited Competition: AIDS Malignancy Clinical Trials Consortium (UM1)

Funding Opportunity Number: RFA-CA-14-502 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCFDA Number: 93.39393.39493.39593.396Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: Jan 06, 2015Award Ceiling: $21,400,000Expected Number of Awards: 1Creation Date: Aug 08, 2014Funding Opportunity Description: The purpose of this limited competition funding opportunity announcement (FOA) is to continue support of the research activities of the AIDS Malignancy Consortium which are: 1) design, development, and evaluation of clinical interventions for the prevention and treatment of malignancies in patients with HIV infection; 2) development of more effective management and therapeutics for HIV-associated malignancies; 3) investigation of the biology of HIV malignancies within the context of clinical trials; 4) management of issues of international importance in HIV-associated-malignancies; and 5) distribution of excess tumor tissue and other relevant biologic fluids to the AIDS and Cancer Specimen Resource for ongoing or future investigations. In addition, the AMC is expected to continue the development and execution of the "ANCHOR" study on the treatment of anal cancer high-grade squamous intraepithelial lesions (HSIL) to reduce anal cancer. In the current funding period, t...
Source: Grants.gov - Category: Research Tags: Education Health Source Type: funding